Literature DB >> 16528796

Insights into different results from different causal contrasts in the presence of effect-measure modification.

Til Stürmer1, Kenneth J Rothman, Robert J Glynn.   

Abstract

PURPOSE: Both propensity score (PS) matching and inverse probability of treatment weighting (IPTW) allow causal contrasts, albeit different ones. In the presence of effect-measure modification, different analytic approaches produce different summary estimates.
METHODS: We present a spreadsheet example that assumes a dichotomous exposure, covariate, and outcome. The covariate can be a confounder or not and a modifier of the relative risk (RR) or not. Based on expected cell counts, we calculate RR estimates using five summary estimators: Mantel-Haenszel (MH), maximum likelihood (ML), the standardized mortality ratio (SMR), PS matching, and a common implementation of IPTW.
RESULTS: Without effect-measure modification, all approaches produce identical results. In the presence of effect-measure modification and regardless of the presence of confounding, results from the SMR and PS are identical, but IPTW can produce strikingly different results (e.g., RR = 0.83 vs. RR = 1.50). In such settings, MH and ML do not estimate a population parameter and results for those measures fall between PS and IPTW.
CONCLUSIONS: Discrepancies between PS and IPTW reflect different weighting of stratum-specific effect estimates. SMR and PS matching assign weights according to the distribution of the effect-measure modifier in the exposed subpopulation, whereas IPTW assigns weights according to the distribution of the entire study population. In pharmacoepidemiology, contraindications to treatment that also modify the effect might be prevalent in the population, but would be rare among the exposed. In such settings, estimating the effect of exposure in the exposed rather than the whole population is preferable. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2006        PMID: 16528796      PMCID: PMC1581494          DOI: 10.1002/pds.1231

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  21 in total

1.  Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

Authors:  M A Hernán; B Brumback; J M Robins
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

2.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

3.  Marginal structural models as a tool for standardization.

Authors:  Tosiya Sato; Yutaka Matsuyama
Journal:  Epidemiology       Date:  2003-11       Impact factor: 4.822

4.  Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study.

Authors:  Jared K Lunceford; Marie Davidian
Journal:  Stat Med       Date:  2004-10-15       Impact factor: 2.373

5.  Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect.

Authors:  Tobias Kurth; Alexander M Walker; Robert J Glynn; K Arnold Chan; J Michael Gaziano; Klaus Berger; James M Robins
Journal:  Am J Epidemiol       Date:  2005-12-21       Impact factor: 4.897

Review 6.  A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods.

Authors:  Til Stürmer; Manisha Joshi; Robert J Glynn; Jerry Avorn; Kenneth J Rothman; Sebastian Schneeweiss
Journal:  J Clin Epidemiol       Date:  2005-10-13       Impact factor: 6.437

7.  Components of the crude risk ratio.

Authors:  O S Miettinen
Journal:  Am J Epidemiol       Date:  1972-08       Impact factor: 4.897

8.  Standardization of risk ratios.

Authors:  O S Miettinen
Journal:  Am J Epidemiol       Date:  1972-12       Impact factor: 4.897

9.  Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.

Authors:  Peter U Heuschmann; Klaus Berger; Bjoern Misselwitz; Peter Hermanek; Carsten Leffmann; Michael Adelmann; Hans-Joachim Buecker-Nott; Joachim Rother; Bernhard Neundoerfer; Peter L Kolominsky-Rabas
Journal:  Stroke       Date:  2003-03-27       Impact factor: 7.914

Review 10.  Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Daniel E Singer; Gregory W Albers; James E Dalen; Alan S Go; Jonathan L Halperin; Warren J Manning
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

View more
  53 in total

1.  Thiazolidinedione use and ulcerative colitis-related flares: an exploratory analysis of administrative data.

Authors:  Jennifer L Lund; Til Stürmer; Carol Q Porter; Robert S Sandler; Michael D Kappelman
Journal:  Inflamm Bowel Dis       Date:  2011-03       Impact factor: 5.325

2.  Dipeptidyl peptidase-4 inhibitors lower the risk of autoimmune disease in patients with type 2 diabetes mellitus: A nationwide population-based cohort study.

Authors:  Jong-Mi Seong; Jeong Yee; Hye Sun Gwak
Journal:  Br J Clin Pharmacol       Date:  2019-06-04       Impact factor: 4.335

3.  Propensity score methods for confounding control in nonexperimental research.

Authors:  M Alan Brookhart; Richard Wyss; J Bradley Layton; Til Stürmer
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-09-10

4.  Incidence of opioid-managed pelvic pain after hysteroscopic sterilization versus laparoscopic sterilization, US 2005-2012.

Authors:  Mitchell M Conover; Jennifer O Howell; Jennifer M Wu; Alan C Kinlaw; Nabarun Dasgupta; Michele Jonsson Funk
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-03-31       Impact factor: 2.890

Review 5.  Developments in post-marketing comparative effectiveness research.

Authors:  S Schneeweiss
Journal:  Clin Pharmacol Ther       Date:  2007-06-06       Impact factor: 6.875

6.  Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results.

Authors:  Sebastian Schneeweiss; Amanda R Patrick; Til Stürmer; M Alan Brookhart; Jerry Avorn; Malcolm Maclure; Kenneth J Rothman; Robert J Glynn
Journal:  Med Care       Date:  2007-10       Impact factor: 2.983

7.  Pharmacoepidemiology and "in silico" drug evaluation: is there common ground?

Authors:  Til Stürmer; Kenneth J Rothman; Jerry Avorn
Journal:  J Clin Epidemiol       Date:  2008-03       Impact factor: 6.437

8.  Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs.

Authors:  T Stürmer; R Wyss; R J Glynn; M A Brookhart
Journal:  J Intern Med       Date:  2014-02-13       Impact factor: 8.989

Review 9.  Propensity score methods to control for confounding in observational cohort studies: a statistical primer and application to endoscopy research.

Authors:  Jeff Y Yang; Michael Webster-Clark; Jennifer L Lund; Robert S Sandler; Evan S Dellon; Til Stürmer
Journal:  Gastrointest Endosc       Date:  2019-04-30       Impact factor: 9.427

10.  Toward a better understanding of when to apply propensity scoring: a comparison with conventional regression in ethnic disparities research.

Authors:  Yu Ye; Jason C Bond; Laura A Schmidt; Nina Mulia; Tammy W Tam
Journal:  Ann Epidemiol       Date:  2012-08-14       Impact factor: 3.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.